Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2-Reference-Cited by-同舟云学术

Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2

Published:2018-04-25 Issue:5 Volume:20 Page:586-596
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Choi Jaewoo,Lee Kyutae,Ingvarsdottir Kristin,Bonasio Roberto^ORCID,Saraf Anita,Florens Laurence,Washburn Michael P.^ORCID,Tadros Saber,Green Michael R.^ORCID,Busino Luca^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/s41556-018-0084-5.pdf

Reference68 articles.

1. Yang, Y. & Staudt, L. M. Protein ubiquitination in lymphoid malignancies. Immunol. Rev. 263, 240–256 (2015).

2. Gupta-Rossi, N. et al. Specific over-expression of deltex and a new kelch-like protein in human germinal center B cells. Mol. Immunol. 39, 791–799 (2003).

3. Kroll, J. et al. The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation. Mol. Cell Biol. 25, 8531–8540 (2005).

4. Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298–303 (2011).

5. Lohr, J. G. et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl Acad. Sci. USA 109, 3879–3884 (2012).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuning Responses to Polatuzumab Vedotin in B-cell Lymphoma;Cancer Discovery;2024-09-03

2. KLHL20 and its role in cell homeostasis: A new perspective and therapeutic potential;Life Sciences;2024-09

3. Prevention and treatment of peri-implant fibrosis by functionally inhibiting skeletal cells expressing the leptin receptor;Nature Biomedical Engineering;2024-07-31

4. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

5. Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma;Cancer Discovery;2024-04-25